About the Product

Description


Pantoprazole 40mg + Itopride 150mg capsule is a combination gastrointestinal therapy designed for effective management of acid-related disorders associated with impaired gastric motility.

Pantoprazole works by suppressing gastric acid secretion, while itopride enhances gastrointestinal motility and gastric emptying, helping relieve symptoms such as acidity, bloating, nausea, and early satiety.

This capsule is commonly prescribed for gastroesophageal reflux disease (GERD), functional dyspepsia, chronic gastritis, and conditions involving delayed gastric emptying.

With dual-action benefits, strong prescription acceptance, and relevance in long-term gastric care, this formulation strengthens a digestive healthcare portfolio and supports sustained market demand.

Common side effects may include headache, diarrhea, abdominal discomfort, dizziness, nausea, and flatulence. Most side effects are mild and transient.

Panpital IT Capsule is indicated for the management of gastroesophageal reflux disease (GERD), functional dyspepsia, acid-peptic disorders, gastritis, bloating, nausea, and delayed gastric emptying, as advised by a healthcare professional.

For oral use only. Use under medical supervision. The capsule should be swallowed whole and not crushed or chewed. Inform your doctor about any existing medical conditions or ongoing medications before use.

Store below 25°C in a cool, dry place. Protect from moisture and direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Panpital IT Capsule in the PCD pharma franchise market?

Panpital IT Capsule, containing Pantoprazole 40mg and Itopride 150mg, has strong demand in the gastroenterology and digestive care segment, making it a profitable product for medical distributors, wholesalers, and pharma franchise partners looking to expand their gastrointestinal care portfolio.

Why should medical distributors include Panpital IT Capsule in their product range?

Medical distributors and agencies can benefit from the consistent market demand for medicines used in acidity, GERD, indigestion, bloating, and gastric motility disorders. Panpital IT Capsule helps strengthen a comprehensive gastro care product portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for Panpital IT Capsule?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Panpital IT Capsule with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for Panpital IT Capsule distribution?

Wholesalers and medical agencies benefit from attractive business margins, reliable product availability, professional support, and access to a trusted gastrointestinal care product range when partnering for Panpital IT Capsule distribution.

How can I become a distributor or franchise partner for Panpital IT Capsule?

Medical distributors, stockists, and wholesalers interested in Panpital IT Capsule can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.